{"url":"https://lda.senate.gov/api/v1/filings/89403607-bca2-46a0-8d72-d2ed830bedbc/","filing_uuid":"89403607-bca2-46a0-8d72-d2ed830bedbc","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2024,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/89403607-bca2-46a0-8d72-d2ed830bedbc/print/","filing_document_content_type":"text/html","income":null,"expenses":"80000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brina Dillon","dt_posted":"2025-01-21T12:05:21-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 Summer Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02210","registrant":{"id":401105594,"url":"https://lda.senate.gov/api/v1/registrants/401105594/","house_registrant_id":null,"name":"FOUNDATION MEDICINE, INC.","description":"Develop, manufacture and sell genomic analysis oncology diagnostics","address_1":"400 Summer Street","address_2":null,"address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02210","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANDREA CORBETT","contact_telephone":"+1 617-418-2200","dt_updated":"2026-07-16T11:25:07.889306-04:00"},"client":{"id":205754,"url":"https://lda.senate.gov/api/v1/clients/205754/","client_id":12,"name":"FOUNDATION MEDICINE, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-02-24"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"- Diagnostic regulatory reforms, including the Verifying Accurate Leading-edge IVCT Development Act of 2023 (H.R.2369) and the pilot program for Oncology Drug Products Used with Certain In Vitro Diagnostic Tests","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72883,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"ROMANS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}